{"nct_id":"NCT02734615","title":"Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers","status":"TERMINATED","status_verified_date":"2022-07","start_date":"2016-06-14","start_date_type":"ACTUAL","primary_completion_date":"2021-09-13","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-13","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}